{
    "nct_id": "NCT06508827",
    "official_title": "Iron with Standard of Care Immunotherapy in Melanoma",
    "inclusion_criteria": "1. â‰¥ 18 years old adults at the time of informed consent\n2. Ability to provide written informed consent and HIPAA authorization\n3. Biopsy confirmed melanoma\n4. Eligible for standard of care treatment\n5. Plan to undergo immunotherapy in neoadjuvant or metastatic setting\n6. ECOG performance status 0-2\n7. Anemia defined as hemoglobin < 13 g/dl in addition to ferritin < 100 ng/ml and/or transferrin saturation < 30%\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. History of anaphylactic reaction to intravenous iron or any proposed standard of care treatments\n2. Diagnosis of hemoglobinopathies\n3. Therapeutic Iron supplementation in the past 3 months (oral iron as part of MVI allowed)\n4. Diagnosis of hemochromatosis\n5. Symptomatic brain metastases that require local treatment (brain metastasis which will be treated with systemic immunotherapy or treated metastasis with without need for steroids for symptomatic management are eligible).\n6. Pregnant or lactating female adults\n7. Active infections which in research teams' opinion increases risk for toxicities\n8. Any condition that in the opinion of PI may interfere with patient being able to complete the required procedures.",
    "miscellaneous_criteria": ""
}